• VCs Are Pouring Billions into Biotech in 2018 biospace
    March 07, 2018
    With tax reform in place and corporations expecting lower taxes and easier access to overseas cash, the biopharma industry focus has been on potential merger-and-acquisition activity.
PharmaSources Customer Service